Journal
Stay on top of industry trends and learn how Calyx is helping sponsors and CROs design and implement clinical trials effectively—and efficiently.
Special Considerations for RTSM in Rare Disease Trials: Site/Patient Numbers and Reducing Wastage
CapVest’s GLO Healthcare completes acquisition of Calyx, a Global leader in the delivery of improved outcomes from clinical trials
Revisiting Calyx’s Most Sought After 2022 Content
Top 10 Pharma Company Reduces Drug Wastage through Adoption of Calyx IRT Medication Pooling
